Biomanufacturing holds a $30T opportunity to reimagine supply chains across industries. Yet promising breakthroughs often fail when scaled to commercial production, driving up costs and delaying the market entry of biomaterials. In the AI era, Biological Systems Intelligence can finally integrate genetic and environmental optimization, together, to make scale-up predictable. Learn how AI built for biomanufacturing’s data, workflows, and commercial realities can deliver fewer surprises, faster timelines, and higher yields at industrial scale.
Featuring: Relly Brandman, Moonshot Lead, X, The Moonshot Factory
This presentation was recorded at Bio Innovations Midwest on 15-16 September 2025. Find out more about the event, the only commercially focused event for the industrial biomanufacturing community in North America, here: https://www.bioinnovationsmidwest.com/
